about
Chitosan based hydrogels: characteristics and pharmaceutical applicationsGelation process visualized by aggregation-induced emission fluorogensImportance and globalization status of good manufacturing practice (GMP) requirements for pharmaceutical excipientsDrug Carriers: Not an Innocent Delivery ManZwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine releaseNanoparticle mediated P-glycoprotein silencing for improved drug delivery across the blood-brain barrier: a siRNA-chitosan approachA study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.Ultrasound treatment increases transfection efficiency of low molecular weight chitosan in fibroblasts but not in KB cells.New chitosan nanobubbles for ultrasound-mediated gene delivery: preparation and in vitro characterization.Biocompatibility of chitosan carriers with application in drug delivery.Complementary and alternative medicine for the treatment of obesity: a critical reviewIn vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis.Effect of Supplementation With Chitosan on Weight, Cardiometabolic, and Other Risk Indices in Wistar Rats Fed Normal and High-Fat/High-Cholesterol Diets Ad Libitum.Chitosan hydrogel as siRNA vector for prolonged gene silencing.Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.Chitosan modification and pharmaceutical/biomedical applications.Preparation and characterization of magnetic alginate-chitosan hydrogel beads loaded matrine.Zwitterionic chitosan derivatives for pH-sensitive stealth coating.Assessment of chitosan-affected metabolic response by peroxisome proliferator-activated receptor bioluminescent imaging-guided transcriptomic analysis.In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccinesMulti-functional roles of chitosan as a potential protective agent against obesity.Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.Development of innovative oil-core self-organized nanovesicles prepared with chitosan and lecithin using a 2(3) full-factorial design.Does the use of chitosan contribute to oxalate kidney stone formation?Pharmacokinetics study of bio-adhesive tablet of Panax notoginseng saponinsIncorporation of copper into chitosan scaffolds promotes bone regeneration in rat calvarial defectsStability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.The Influence of Chitosan on the Oral Bioavailability of Acyclovir--a Comparative Bioavailability Study in Humans.Prawn Shell Chitosan Exhibits Anti-Obesogenic Potential through Alterations to Appetite, Affecting Feeding Behaviour and Satiety Signals In Vivo.A single oral dose of a polyglucosamine influences the bioavailability of [9-(14)C]-Oleic acid in adult female Göttingen minipigsPharmacokinetics, tissue distribution, and metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MS.Chitosan dressing promotes healing in third degree burns in mice: gene expression analysis shows biphasic effects for rapid tissue regeneration and decreased fibrotic signaling.PolySTAT-modified chitosan gauzes for improved hemostasis in external hemorrhage.Dense chitosan surgical membranes produced by a coincident compression-dehydration process.Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditisCharge affects the oral toxicity of poly(amidoamine) dendrimers.Fabrication of functional hollow microspheres constructed from MOF shells: Promising drug delivery systems with high loading capacity and targeted transport.Adaptation of targeted nanocarriers to changing requirements in antimalarial drug deliveryChitosan-Based Nanomedicine to Fight Genital Candida Infections: Chitosomes.Review of antimicrobial and antioxidative activities of chitosans in food.
P2860
Q26782711-36D0BFB9-6725-44AD-8C2E-AD756770E9F5Q27340963-98ADD78E-1E91-4B3F-A2E1-B70696EABAD3Q28082369-A7F66885-913F-4E6D-88AE-3798E3126A1EQ28082414-01CB4D49-2F59-408B-AB17-9B4CFACD023DQ28479064-7541AEA6-ADE2-4FA6-97AF-8597E7A3EAA2Q28485257-A7EEB3D6-A448-4CE8-A30B-52BD23D84522Q30423922-C7FE8D76-92E1-46E5-B2F0-CD03E4F95AB8Q30441211-70F73556-7FA2-46F3-A4A8-2CA1BEF84A6DQ30465691-18ED9699-0973-41BE-A58A-D2865C674153Q33649839-2220229C-5036-4BC7-84CD-81F05EC25316Q33686271-B32D6311-B93A-49E7-B122-F86E1B58FDD7Q33709398-5C8C2C43-3D79-4F42-B839-F7FCAE5DEE85Q33724500-3C194205-2337-4A07-B718-9DDE1EB114F0Q33925196-BF1E07D2-9155-4C44-8CA6-E945E1225EF9Q34033764-03158C1B-D1EB-461B-BDF4-7E7D38D9E9F9Q34061817-CC226314-13C4-4D30-9BD1-0AAE391BDC63Q34076504-59C7E8F7-0D22-46EC-8289-C966EF83BDE1Q34139159-8098512D-7246-461F-AFA9-C022CE758C65Q34230420-A839CA6E-B18B-481C-A7E1-37075B3FD9AFQ34356322-DD3BBE36-993B-4AF1-902D-2EA492CBC71AQ34558788-06026F2E-DD49-4DA4-B81D-11DC23201F77Q34733812-D2AA0E27-414A-4B0D-A428-238F95A601ECQ34977425-5F44EFCC-B2A2-490E-A286-FA26E9E63E73Q35015313-C7C27CAE-008C-4401-9180-C3072CF7033BQ35063665-32C96E83-9D13-48F5-B32F-C2E231CA9B4DQ35187152-2FC2F9DD-CA8C-46C5-A8BF-D94AA0B90561Q35661857-9B1E05F0-5540-4AC6-B9D8-538CA6C42307Q35674423-8FCEE0CF-C815-4DB7-8993-ACC1CB3FB13EQ35931352-B94DB274-FCC9-43CA-A0A0-9741899A11EFQ35962039-FFD5D5FC-901E-4559-BA4F-C85A1C93559FQ35972507-879363A9-E4C2-46C9-9304-09E5AF1EFA85Q36368387-0B3C1B44-4D02-48E8-8520-007817B7B540Q36505721-B575BC8C-ADB5-4368-BBF2-55988B82E993Q36756873-F5290D90-D90F-45EC-9C72-19276FA99C5BQ36977614-D03184A6-7206-4503-ACEE-BDE4D8BF66BBQ37386295-8E3FAFC5-0B2A-4A09-A197-138666520CD7Q37431026-C0B7C18D-BB62-4B2D-86EB-F9201CB57C90Q37675691-D2E5CBFB-5577-4A72-98E7-A2FCFAB49AF5Q37721812-FC77C744-5154-4A44-A044-FFEA0EB9E40EQ37786660-67CE24FD-C8F2-4354-8F9F-C1A0DDF3026E
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
The safety of chitosan as a pharmaceutical excipient.
@ast
The safety of chitosan as a pharmaceutical excipient.
@en
type
label
The safety of chitosan as a pharmaceutical excipient.
@ast
The safety of chitosan as a pharmaceutical excipient.
@en
prefLabel
The safety of chitosan as a pharmaceutical excipient.
@ast
The safety of chitosan as a pharmaceutical excipient.
@en
P1476
The safety of chitosan as a pharmaceutical excipient.
@en
P2093
Paul Baldrick
P304
P356
10.1016/J.YRTPH.2009.09.015
P407
P577
2009-09-27T00:00:00Z